6,7-dimethoxy-4-[4-(5-phenylsulfanylpyrimidin-2-yl)piperazin-1-yl]quinazoline;4-[4-[5-[(3-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline
C74H74F2N18O6S — CID 158173503
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6,7-dimethoxy-4-[4-(5-phenylsulfanylpyrimidin-2-yl)piperazin-1-yl]quinazoline;4-[4-[5-[(3-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline
6,7-dimethoxy-4-[4-(5-phenylsulfanylpyrimidin-2-yl)piperazin-1-yl]quinazoline;4-[4-[5-[(3-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline (PubChem CID 158173503) has the molecular formula C74H74F2N18O6S and a molecular weight of 1381.59 g/mol. Its IUPAC name is 6,7-dimethoxy-4-[4-(5-phenylsulfanylpyrimidin-2-yl)piperazin-1-yl]quinazoline;4-[4-[5-[(3-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline.
Molecular Properties
| Compound Name | 6,7-dimethoxy-4-[4-(5-phenylsulfanylpyrimidin-2-yl)piperazin-1-yl]quinazoline;4-[4-[5-[(3-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline |
|---|---|
| PubChem CID | 158173503 |
| Molecular Formula | C74H74F2N18O6S |
| Molecular Weight | 1381.59 g/mol |
| Exact Mass | 1380.57 |
| IUPAC Name | 6,7-dimethoxy-4-[4-(5-phenylsulfanylpyrimidin-2-yl)piperazin-1-yl]quinazoline;4-[4-[5-[(3-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline;4-[4-[5-[(4-fluorophenyl)methyl]pyrimidin-2-yl]piperazin-1-yl]-6,7-dimethoxyquinazoline |
| SMILES | COc1cc2ncnc(N3CCN(c4ncc(Cc5ccc(F)cc5)cn4)CC3)c2cc1OC.COc1cc2ncnc(N3CCN(c4ncc(Cc5cccc(F)c5)cn4)CC3)c2cc1OC.COc1cc2ncnc(N3CCN(c4ncc(Sc5ccccc5)cn4)CC3)c2cc1OC |
| InChI | InChI=1S/2C25H25FN6O2.C24H24N6O2S/c1-33-22-12-20-21(13-23(22)34-2)29-16-30-24(20)31-7-9-32(10-8-31)25-27-14-18(15-28-25)11-17-3-5-19(26)6-4-17;1-33-22-12-20-21(13-23(22)34-2)29-16-30-24(20)31-6-8-32(9-7-31)25-27-14-18(15-28-25)10-17-4-3-5-19(26)11-17;1-31-21-12-19-20(13-22(21)32-2)27-16-28-23(19)29-8-10-30(11-9-29)24-25-14-18(15-26-24)33-17-6-4-3-5-7-17/h3-6,12-16H,7-11H2,1-2H3;3-5,11-16H,6-10H2,1-2H3;3-7,12-16H,8-11H2,1-2H3 |
| InChIKey | FXSSWSNPIFKUQL-UHFFFAOYSA-N |
| XLogP | 10.90 |
| TPSA | 229.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 101 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1381.59 |
| LogP ≤ 5 | 10.90 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 25 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158173503 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.